We are live on
!
Find out more
HZ
Hixon Zuercher Portfolio holdings
AUM
$341M
1-Year Est. Return
26.01%
This Fund
S&P 500
This Quarter
Est. Return
-3.82%
1 Year Est. Return
+26.01%
3 Year Est. Return
+87.54%
5 Year Est. Return
+113.51%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$2.23M
(+1.4%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
7%
Top 10 Holdings %
Top 10 Hldgs %
40.5%
Holding
59
New
2
Increased
44
Reduced
2
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$1.99M |
| 2 |
Air Products & Chemicals
APD
|
+$1.66M |
| 3 |
Goldman Sachs ActiveBeta International Equity ETF
GSIE
|
+$659K |
| 4 |
Walmart Inc
WMT
|
+$455K |
| 5 |
Marathon Petroleum
MPC
|
+$437K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.93M |
| 2 |
3M
MMM
|
+$246K |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$232K |
| 4 |
Nike
NKE
|
+$207K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Consumer Discretionary | 13.8% |
| 3 | Financials | 13.78% |
| 4 | Healthcare | 11.83% |
| 5 | Consumer Staples | 10.78% |
Similar funds
MTIC
KFSC
CPI
EC
FCM
SWK
SW
SM
Hixon Zuercher's Q3 2022 Portfolio in Review
As of Q3 2022, Hixon Zuercher held 59 positions worth $157M, up 1.4% from $154M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Hixon Zuercher deployed $11M of net new capital in Q3 2022, opening 2 new positions and adding to 44 existing holdings. Its largest new stake was Air Products & Chemicals: 6,714 shares worth $1.56M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $1.93M trimmed.
- Hixon Zuercher's largest Q3 2022 buy was Air Products & Chemicals: 6,714 shares worth $1.56M.
- Hixon Zuercher added most to Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q3 2022, an estimated $1.99M increase.
- Hixon Zuercher's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $1.93M.
- Hixon Zuercher fully exited 3M in Q3 2022, selling an estimated $246K.
- Hixon Zuercher's ten largest holdings make up 40% of its $157M portfolio in Q3 2022.
- Hixon Zuercher opened 2 new positions and closed 5 in Q3 2022.
- Hixon Zuercher's portfolio value rose 1.4% quarter-over-quarter to $157M.
Based on Hixon Zuercher's 13F filing for Q3 2022, filed 26 Oct 2022.